RETRACTABLE TECHNOLOGIES INC Net Change in Cash
RETRACTABLE TECHNOLOGIES INC (RVP) reported Net Change in Cash of $52.42 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-14
- RETRACTABLE TECHNOLOGIES INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $177.27K.
- RETRACTABLE TECHNOLOGIES INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$852.47K.
- RETRACTABLE TECHNOLOGIES INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$2.66M.
- RETRACTABLE TECHNOLOGIES INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$13.36M, a 195.78% decline year-over-year.
- RETRACTABLE TECHNOLOGIES INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$1.65M.
- RETRACTABLE TECHNOLOGIES INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$8.43M.
- RETRACTABLE TECHNOLOGIES INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$7.05M.
- RETRACTABLE TECHNOLOGIES INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$9.44M, a 181.42% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $52.42K 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $177.27K 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | -$1.65M 10-K · filed 2026-03-27 | |||
| 2025-09-30 | -$790.85K 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | -$1.19M 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | -$852.47K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | -$8.43M 10-K · filed 2026-03-27 | |||
| 2024-09-30 | -$8.75M 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | -$5.81M 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | -$2.66M 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$7.05M 10-K · filed 2026-03-27 | |||
| 2023-09-30 | -$8.46M 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | -$15.58M 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | -$13.36M 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$9.44M 10-K · filed 2025-03-28 | |||
| 2022-09-30 | -$15.75M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$8.72M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $13.95M 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $11.60M 10-K · filed 2024-03-29 | |||
| 2021-09-30 | -$1.20M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $4.87M 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | $13.36M 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $11.63M 10-K · filed 2023-03-30 | |||
| 2020-09-30 | $9.78M 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | -$629.65K 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | $1.67M 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | -$3.71M 10-K · filed 2022-03-31 | |||
| 2019-09-30 | -$4.09M 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | -$5.88M 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | -$5.42M 10-Q · filed 2020-05-15 | |||
| 2018-12-31 | -$5.23M 10-K · filed 2021-03-31 | |||
| 2018-09-30 | -$1.24M 10-Q · filed 2019-11-14 | |||
| 2018-06-30 | -$2.03M 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $216.36K 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | -$1.32M 10-K · filed 2020-03-30 | |||
| 2017-09-30 | -$332.58K 10-Q · filed 2018-11-14 | |||
| 2016-12-31 | -$1.85M 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |